Description
Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)
€3.03
Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)
You must be logged in to post a review.
Reviews
There are no reviews yet.